✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals
Market Cap
₹669 Cr.
P/E
44.56

Key Ratios

Market cap
Market cap
669 Cr
PE
PE
44.56
Prom Holding
Prom Holding
47.37 %
ROE (%)
ROE (%)
4.02
ROCE (%)
ROCE (%)
6.08
Div Yield (%)
Div Yield (%)
0.12
Sales
Sales
326 Cr
OPM (%)
OPM (%)
12.81 %
Debt to Equity
Debt to Equity
0.30

About

Shivalik Rasayan Ltd. (SRL), established in 1981, is a manufacturer of organophosphorous based… Read more
Low
410
52W Range
High
874
  • Shivalik Rasayan
  • Fredun Pharma
  • Prevest Denpro
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Capacity Utilization - Dimethoate (%)
    • Realization/Tonne - Dimethoate (Rs/MT)
    • Realization/Tonne - Sodium hydrosulfide (Rs/MT)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Shivalik Rasayan Ltd. Business

    Established in 1981, Shivalik Rasayan Ltd. (SRL) is a leading manufacturer of international quality Malathion Technical and Dimethoate Technical, well established in Indian and foreign markets.

    Shivalik Rasayan major competitors are Fredun Pharma, Prevest Denpro, Kilitch Drugs(India), Venus Remedies, Sakar Healthcare, Anuh Pharma, Ind-Swift Lab..
    Market Cap of Shivalik Rasayan is ₹669 Crs.
    While the median market cap of its peers are ₹709 Crs.

    Shivalik Rasayan seems to be less financially stable compared to its competitors.
    Altman Z score of Shivalik Rasayan is 2.8 and is ranked 8 out of its 8 competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Dec
    Investor Presentation Sep Jun Mar Dec Jun Sep Jun Sep
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material